retatrutide regulatory approval Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation Retatrutide approval: FDA status, clinical

Nyborg, N

Studies show GLP-1s can increase stomach contents, but they havent clearly been linked to more aspiration during surgery

CMS, meanwhile, remains responsible for program costs, pharmacy payments and beneficiary communications, among other efforts

In this article, well explore how Retatrutide works, the latest clinical trial results, who it could help, when it might be available, andif you read to the endhow you might be able to participate in a clinical trial for it

What Does a GLP-1 Receptor Agonist Actually Do

Pratley, MD, medical director of Advent Translational Research Institute and AdventHealth Diabetes Institute in Orlando, Florida